Cure HHT
Nicole Schaefer is the current Chief Operating Officer at Cure HHT since September 2006. Nicole also holds the position of Director of Professional & Medical Programs at the same organization. Prior to their role at Cure HHT, Nicole worked as a Benefits Manager at E.I.L. Instruments, Inc. from 1989 to 1996. Nicole attended the University of Michigan from 1983 to 1987.
Cure HHT
HHT afflicts the lives of more than 1.4 million people worldwide with most unaware that "nosebleeds in the family" can be something much more and potentially life threatening. The HHT Foundation is the only patient advocacy organization in the world solely focused on individuals living with this disease. You can be sure that your investment in the HHT Foundation will go to the highest-return initiatives that can improve life of HHT patients today and in future generations by: - Providing "seed money" for research on promising therapies - Improving access to care by adding more HHT Treatment Centers - Building a registry of HHT patients to find which treatments work best - Standardizing HHT treatments to ensure patients get global best practices